According to the statistics of the reporters of the science and technology innovation board daily, as of August 9, 16 companies have announced plans to reduce their holdings, involving shareholders or (and) directors, supervisors and senior executives of the companies. Most of the reduction periods are within three or six months after the prescribed date.
In the wave of reducing shares in the science and technology innovation board, the main force is venture capital institutions, and star institutions such as Shenzhen Venture Capital, Dachen and Songhe are all on this list. According to media statistics, venture capital funds accounted for 80% of the total scale of the reduction.
Taking fangbang shares as an example, the shareholder Songhe venture capital intends to reduce its holding of no more than 4 million shares within 3 months after the specified date, accounting for 68.43% of the companys shares (5.8458 million shares, accounting for 7.31% of the companys total share capital). Based on the closing price of fangbang shares on August 7 and the investment cost of Songhe venture capital of 5.8458 million yuan, Songhe venture capitals reduction income will reach 629 million yuan, and the corresponding rate of return will exceed 100 times.
It is worth mentioning that hongruan technology, jept, Pumen technology and Tianyi Shangjia, which are jointly owned by Songhe, will also be listed and circulated in the second half of the year.
The announcement also showed that Shenzhen Venture Capital also plans to reduce its holdings of no more than 26.4763 million shares (no more than 6% of the total share capital of the company) in the form of centralized bidding and block trading, accounting for 52.34% of its total shares (50581000 shares, 11.46% of the total shares of the company). According to the reporters estimate of science and technology innovation board daily, the reduction will bring 612 million yuan of income for Shenzhen Venture Capital, with the corresponding yield of nearly 10 times.
In the second half of the year, jiuri new materials, RuiChuang micro nano and micro core Biology (including the aforementioned Western superconductor, jept and Hopman Technology) invested by Shenzhen Venture Capital will also face the lifting of the ban.
In the second half of the year, the ban of ambotong, redview and Longruan technologies will also be lifted.
November will usher in the second wave peak
In the second half of the year, Borui pharmaceutical, a company invested by Sequoia Capital, Lexin Technology Co invested by Saifu, and Changyang technology, which is invested by Tongchuang, will all face the lifting of the ban.
From the perspective of the scale of single companys lifting the ban, 9 companies with a market value of more than 10 billion yuan in the second half of the year, including Jinshan office, Zhongwei company, LanChi technology, voice holding, hongruan technology, microchip biology, RuiChuang micro nano, Anheng information and Jingchen Co., Ltd.
From October to November, the second wave of large-scale lifting of the ban on the science and technology innovation board was launched
However, in the view of professionals, the lifting of the ban is by no means a flood; from the perspective of the recent market situation, the lifting of the ban has not brought about a significant impact.
GUI Haoming, chief market expert of Shenwan Hongyuan, said in an interview with the reporter of kechuangboard daily that the recent market performance was actually better than expected, and continued to rise after a short adjustment after the first wave of lifting the ban. There are three main reasons: first, many stocks of the science and technology innovation board usually show strong performance growth momentum, which makes the high P / E ratio in the past issuance decline, and also provides investors with the opportunity to make long-term investment; second, the new regulation of reducing holdings effectively solves the pressure caused by concentrated cash arbitrage in a short period of time; third, the relevant provisions require the reduction of holding in excess of the prescribed part The announcement must be made in advance, and the reduction in time has also been substantially delayed.
Guosheng securities research, on the contrary, will bring greater opportunities. On the one hand, the lifting of the ban may have a short-term impact on the market, but the impact is relatively limited. On the contrary, it may be a golden pit. On the other hand, with the lifting of the ban and the expansion of circulation chips, it will provide the institutions with more opportunities to enter the science and technology innovation board.